Theravance Biopharma Inc. (TBPH)
NASDAQ: TBPH
· Real-Time Price · USD
13.14
0.20 (1.55%)
At close: Aug 15, 2025, 3:59 PM
13.16
0.15%
After-hours: Aug 15, 2025, 06:33 PM EDT
Theravance Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 15.39M | 18.75M | 16.87M | 14.26M | 14.5M | 17.57M | 15.69M | 13.75M | 10.42M | 14.65M | 12.45M | 11.05M | 13.2M | 14.95M | 13.19M | 12.91M | 14.26M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 4.33M | 1.34M | 1.34M | 1.66M | 1.25M | 1.63M | 2.23M | 1.48M | 31.23M | 43.74M | 51.09M | 67.6M |
Gross Profit | 15.39M | 18.75M | 16.87M | 14.26M | 14.5M | 13.23M | 14.35M | 12.41M | 8.76M | 13.4M | 10.83M | 8.82M | 11.71M | -16.28M | -30.55M | -38.18M | -53.34M |
Operating Income | -14.43M | -9.2M | -10.84M | -15.71M | -11.21M | -6.24M | -8.76M | -16.12M | -24.91M | -17.43M | -14.2M | 6.86M | -38.5M | -56.17M | -53.62M | -64.11M | -83.89M |
Interest Income | 939K | 904K | 1.42M | 1.13M | 1.43M | 1.85M | 1.79M | 2.5M | 2.98M | 3.72M | 2.76M | 2.44M | n/a | 338K | n/a | 1.17M | n/a |
Pretax Income | -14.14M | -8.94M | -10.05M | -15.22M | -10.4M | -5.02M | -7.58M | -14.19M | -22.48M | -14.26M | -16.02M | -8.2M | -25.42M | -32.19M | -35.31M | -52.63M | -79.45M |
Net Income | -13.58M | -15.53M | -12.7M | -16.53M | -11.66M | -8.51M | -8.95M | -15.64M | -22.09M | -14.26M | 916.63M | -8.19M | -25.95M | -32.03M | -35.31M | -52.41M | -79.68M |
Selling & General & Admin | 18.37M | 18.5M | 16.88M | 17.06M | 16.74M | 15.49M | 16.14M | 19.28M | 19.18M | 16.73M | 16.28M | 16.99M | 23.64M | 21.52M | 21.3M | 25.93M | 30.55M |
Research & Development | 11.45M | 9.45M | 9.27M | 9.95M | 8.97M | 8.31M | 8.31M | 9.43M | 14.57M | 15.35M | 9.87M | 15.57M | 23.25M | 31.23M | 43.74M | 51.09M | 67.6M |
Other Expenses | n/a | n/a | 1.56M | 2.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 29.82M | 27.95M | 27.7M | 29.96M | 25.71M | 23.81M | 24.45M | 28.7M | 33.76M | 32.08M | 26.14M | 32.56M | 46.89M | 52.74M | 65.04M | 77.02M | 98.15M |
Interest Expense | 643K | 643K | 630K | 644K | 629K | 623K | 609K | 568K | 550K | 551K | 1.54M | 2.14M | 12.03M | 11.66M | 11.91M | 11.61M | 12.11M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 5.1M | n/a | n/a | n/a | 8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 29.82M | 27.95M | 27.7M | 29.96M | 25.71M | 23.81M | 24.45M | 28.7M | 33.76M | 32.08M | 26.14M | 32.56M | 46.89M | 52.74M | 65.04M | 77.02M | 98.15M |
Income Tax Expense | -559K | 6.59M | 2.65M | 1.31M | 1.26M | 3.49M | 1.37M | 1.46M | -395K | -3K | n/a | -5K | 524K | -151K | -7K | -220K | 227K |
Shares Outstanding (Basic) | 49.71M | 49.31M | 49.04M | 48.75M | 48.28M | 49.41M | 52.36M | 56.68M | 62.93M | 67.39M | 75.52M | 76.27M | 75.25M | 73.62M | 73.57M | 65.67M | 64.49M |
Shares Outstanding (Diluted) | 49.71M | 49.31M | 49.04M | 48.75M | 48.28M | 49.41M | 52.36M | 56.68M | 62.93M | 67.39M | 75.52M | 76.27M | 75.25M | 73.96M | 73.57M | 65.67M | 64.49M |
EPS (Basic) | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 | -0.17 | -0.17 | -0.28 | -0.35 | -0.21 | 12.14 | -0.11 | -0.34 | -0.44 | -0.48 | -0.8 | -1.24 |
EPS (Diluted) | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 | -0.17 | -0.17 | -0.28 | -0.35 | -0.21 | 12.14 | -0.11 | -0.34 | -0.43 | -0.48 | -0.8 | -1.24 |
EBITDA | -12.44M | -7.6M | -8.66M | -13.6M | -8.59M | -2.67M | -5.63M | -12.28M | -20.28M | -12.46M | -12.85M | -19.16M | -38.5M | -19.5M | -53.62M | -38.62M | -65.3M |
EBIT | -13.49M | -8.3M | -9.42M | -14.58M | -9.77M | -4.39M | -6.97M | -13.62M | -21.93M | -13.71M | -14.48M | 3.69M | -37.22M | -20.52M | -53.62M | -41.01M | -67.34M |
Depreciation & Amortization | 1.05M | 695K | 762K | 979K | 1.18M | 1.72M | 1.34M | 1.34M | 1.66M | 1.25M | 1.63M | 2.23M | 1.48M | 1.03M | 2.63M | 2.4M | 2.28M |